Can a newer pill keep leukemia away longer after stopping treatment?
NCT ID NCT01774630
First seen May 20, 2026 · Last updated May 23, 2026 · Updated 2 times
Summary
This study looked at 31 adults with chronic myeloid leukemia (CML) whose cancer came back after they stopped taking imatinib. They were given nilotinib, a more powerful targeted drug, to see if it could make their cancer undetectable again and allow them to stop treatment for a longer time. The goal was to find out how many patients could stay cancer-free three years after restarting therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH Valence
Valence, 26953, France
-
CH d'Annecy
Pringy, 74374, France
-
CHU Angers
Angers, 49033, France
-
CHU de Nice, Service Hématologie Clinique
Nice, 06202, France
-
CHU de Toulouse, Service d'Hématologie
Toulouse, 31059, France
-
Centre Hospitalier Lyon Sud, Service Hématologie
Pierre-Bénite, 69495, France
-
Centre Hospitalier de Versailles - Hôpital André Mignot - Service de Médecine B
Le Chesnay, 78157, France
-
Hôpital Haut Lévêque, Service Hématologie
Pessac, 33604, France
-
Hôpital Pontchaillou
Rennes, 35033, France
-
Institut Bergonié
Bordeaux, 33076, France
Conditions
Explore the condition pages connected to this study.